clorazepate dipotassium has been researched along with Lung Diseases, Obstructive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cable, T; Eimer, M; Gal, P; McCue, JD; Rothenberger, LA | 1 |
1 trial(s) available for clorazepate dipotassium and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Effects of clorazepate on breathlessness and exercise tolerance in patients with chronic airflow obstruction.
Topics: Aged; Anti-Anxiety Agents; Anxiety; Clinical Trials as Topic; Clorazepate Dipotassium; Double-Blind Method; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Physical Exertion; Psychological Tests; Pulmonary Ventilation; Random Allocation; Respiratory Function Tests | 1985 |